If approved, this would mark the first MDMA-assisted therapy and psychedelic-assisted therapy approved because of the agency, contacting for just a reschedule of MDMA from Schedule I to admit the healthcare benefits of the drug.one,2 In addition, studies have shown impairment in focus and memory